小结
宫颈癌筛查被人们称赞为最成功的医学预防措施之一。 自1941年巴氏涂片应用以来，促使发达国家中宫颈癌的死亡率降低了70%[1][Figure caption and citation for the preceding image starts]: 低度宫颈癌对宫颈造成的侵蚀美国疾病预防控制中心 (CDC) [Citation ends].
American Congress of Obstetricians and Gynecologists: cervical cancer screening Opens in new window
National Cancer Institute: Pap and HIV testing Opens in new window
详细信息
- 宫颈取样技术
- 宫颈细胞学检查
- 人乳头状瘤病毒 (HPV) 检查
- HPV 疫苗
- 阴道镜
- 筛查
撰稿人
作者
Richard T. Penson, MD, MRCP
Clinical Director
Medical Gynecologic Oncology
Division of Hematology Oncology
Massachusetts General Hospital
Boston
MA
利益声明
RTP has received institutional research funding from Array BioPharma Inc., AstraZeneca, Genentech, and Vascular Biogenics Ltd. RTP has been paid for participating in scientific advisory boards for: AbbVie, AstraZeneca, Clovis Oncology, Curio Science, Eisai Inc., Genentech, Janssen Oncology (J&J), Merck & Co., Mersana Therapeutics, Inc., NewLink Genetics, Nexus Global Group, Pieris Pharma Inc, Roche, Inc., Sutro Biopharma, Syndax Pharmaceuticals, Tesaro Inc., and Vascular Biogenics Ltd.
Marcela G. del Carmen, MD, MPH
Chief Medical Officer
Massachusetts General Physicians Organization
Division of Gynecologic-Oncology
Massachusetts General Hospital
Professor
Department of Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
Boston
MA
利益声明
MDC declares that she has no competing interests.
同行评议者
Deirdre Lyons, MB, BCh, BAO, MRCOG
Consultant in Obstetrics & Gynaecology
Lead Clinician in Colposcopy
Imperial College Healthcare NHS Trust
London
UK
利益声明
DL declares that she has no competing interests.
Matejka Rebolj, PhD
Scientific Researcher
Centre for Epidemiology and Screening
Institute of Public Health
University of Copenhagen
Copenhagen
Denmark
利益声明
MR declares that she has no competing interests.
Shagufta Yasmeen, MD
Associate Professor
Department of Obstetrics and Gynecology
UC Davis Health System
Sacramento
CA
利益声明
SY declares that she has no competing interests.
内容使用需遵循免责声明